Evidence map›Paper›PMID 41500980›Full record

ArticlePsycho-oncology2026

Cycling Through Uncertainty: The Psychological Experiences of Individuals With Lung Cancer Receiving Immunotherapy And/Or Targeted Therapy.

Alanna K Chu, Emma Kearns, Celeste Holy, Paul Wheatley-Price, Rinat Nissim, Tim Aubry, Sophie Lebel

Abstract read
In one paragraph

Article in Psycho-oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alanna K ChuUniversity of Ottawa, Ottawa, ON, Canada.ORCID https://orcid.org/0000-0002-0417-2630
Emma KearnsUniversity of Ottawa, Ottawa, ON, Canada.ORCID https://orcid.org/0009-0009-3577-0949
Celeste HolyUniversity of Ottawa, Ottawa, ON, Canada.
Paul Wheatley-PriceThe Ottawa Hospital, Ottawa, ON, Canada.
Rinat NissimPrincess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Tim AubryUniversity of Ottawa, Ottawa, ON, Canada.
Sophie LebelUniversity of Ottawa, Ottawa, ON, Canada.

Funding

Social Sciences and Humanities Research Council 892-2021-0070
6 · The paper itself

Abstract

backgroundThe recent developments in immunotherapy and targeted therapy drugs offer a new hope for prolonging overall survival and improving quality of life in individuals with advanced lung cancer. However, treatment response to these drugs is variable and unpredictable and early research indicates that these individuals are living with distressing uncertainty and unique supportive care needs.

aimsQualitatively characterize the psychological experience of receiving ICI and TT.

methodsThe study design and interview guide were developed with the charitable organization Lung Cancer Canada (LCC) and a patient advisory board. A diverse group of patients with advanced lung cancer receiving immunotherapy or targeted therapy were recruited from across Canada. Qualitative interviews (n = 24) explored their unmet needs using the Supportive Care Framework in Cancer Care. A thematic analysis was conducted.

resultsAll participants described a similar treatment "cycle" associated with similar experiences and psychological concerns at each phase. Participants described shock and distressing uncertainty in illness at the beginning of treatment and during periods of disease and treatment change. Medically stable periods of treatment response were associated with difficulties with adjustment, coping, and finding new meaning in life. Participants described fear of progression and death anxiety in response to uncertainty in disease and treatment. Various psychological (e.g., acceptance, avoidance, meaning-making) and practical (e.g., social support, information seeking) coping strategies were described.

conclusionsAdvocates, clinicians, researchers, and policymakers should be aware of the unique psychological needs of this growing population. Psychological interventions must address illness uncertainty and corresponding fears and worries.

Indexed as

Adaptation, PsychologicalImmunotherapyLung NeoplasmsMolecular Targeted TherapyAdultAgedAnxietyCanadaCoping SkillsFemaleHumansMaleMiddle AgedQualitative ResearchQuality of LifeStress, Psychologicaldeath anxietyfear of progressionimmunotherapysurvivorshiptargeted therapyuncertainty

Identifiers

PMID41500980
PMCPMC12779583

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.